Since 2013, TI Pharma has embarked on a new phase as an independent non-profit that enables international partnership in drug discovery and development.

A number of projects funded by the government’s gas reserve fund (“FES”), either originating from the 2009 Joint Call (JC) or the 2012 SME Partnership Call (SPC) are still running:  

“One of TI Pharma's big strengths is that it knows how to manage money. That's a skill that should be more widespread.”

Tim Wells
Chief Scientific Officer
Medicines for Malaria Venture

Share this page: